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Introduction 
Worldwide overpopulation has brought about lots of 
problems for people especially for developing countries. 
However, there is a success at reduction of population rate 
from 2.1% on 1960 to 1.7 on now (1).
In our country in spite of family planning programs 
for first developing strategies of country the rate of 
population is still high and irregular (2). This has been 
reduced from 3.2% on 1355 to 1.5% on 1377 and 1.4% at 
past tense (1). At 3 previous years this rate has been stable 
1.4% (1,3) which is located among countries with higher 
growth index (1). At some developing countries the risk of 
prenatal mortality and morbidity 10-20 times is more than 
developed countries and this risk is increased by mother 
age and number of pregnancies (3-4). Worldwide research 
show 5800000 women die for prenatal complications and 
1/3-1/4 is related to abortions due to unwanted pregnancies 
(5). 50% of all pregnancies in USA are unwanted and half 
of them are terminated electively (6). In Iran the rate of 
unwanted pregnancies was 44.5% (7). According to report 
WHO (1993), at developing countries elective abortion is 
2nd leading causes of maternal mortality and morbidity 
after hemorrhage (28%). Family planning programs could 
reduce 25-30% of these deaths, complications and other 
congenital malformations because of high risk pregnancies 
(8). Unwanted pregnancies at 36.9% were due to no 
using of Family planning methods and 63.1% by using 
them but 41.7% were using methods with high failure 
rate like natural, calendar, and continuous abstinence 
(7). According to higher rate of unwanted pregnancies 
and higher failure rate of some reversible birth control 
methods there seems to be necessity to use a prolonged 
method like Depot medroxyprogesterone acetate (DMPA) 
which is easy to use, acceptation and comfort for client 
(6). According to report WHO (2000) 16 million women 
world widely use injectable contraceptive which 13 
million of them use DMPA and over 100 countries like 
America use this method (8). Actually the reduction of 
unwanted pregnancies rate at American adults is due to 
use of this method  (6). In Iran the rate of DMPA use 
was reported 2.8% on 2003 (4). In Ardebil city the rate 
of DMPA use was reported 8.66% and 8.91% on 2003 
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and 2004 respectively (8). The 150 mg DMPA is injected 
into a muscle and then is gradually released into the 
bloodstream. It works mainly by stopping ovulation and 
it is given every 12 weeks, makes the lining of the uterus 
thinner and thickens the mucus. It is more effective and its 
failure rate is 0.3% for one year (8-10). Its effectiveness is 
equal with tubal ligation and more effective than OCPs and 
IUD (11). It has some other benefits like reducing the risk 
of endometrial and ovary cancers (6,9,12). It has no drug 
interactions with antibiotics, anticonvulsive and sexual 
activities. There will not be any congenital malformations 
even though the pregnancy occurs soon after drug stop 
(12). It could be prescribed for countries with Sickle cell 
disease and Iron-deficiency anemia (6,12,13). It may 
help protect against pelvic infection. The mucus plug in 
the cervix may help stop bacteria travel into the uterus 
(6,13). It can use by some women who cannot take the 
combined pill which contains estrogen for medical 
reasons. It increases breast milk. Other educated health 
care givers could prescribed it (6). It is accepted by many 
cultures but some users do not continue it for its side-
effects or other worries (6). The main reasons cited for 
discontinuation for first 2 years were weight gain, bleeding 
problems, prolonged amenorrhea, breast tenderness, 
depression, low desire &libido (6,12), Headaches (6,13), 
hair loss (14) and dizziness (6). According to the reasons 
12 month cumulative continuation rate of DMPA differs 
from 25% to 65% and among different population (15-
18). At KAP study on DMPA by Moham Alizade et al. at 
Tabriz 12 month cumulative continuation rate was 0.33% 
and common reason for discontinuation was menstrual 
disorders (14). One reason for these differences (15) could 
be relationship between cumulative continuation rate and 
social-demographic characters which WHO has focused 
on cultural differences in continuation of DMPA use (19). 
There was a relationship between demographic-economic 
conditions, level of education and number of pregnancies 
(20-23). For high and freely providing different birth 
control methods embassy of health and higher education 
spends huge credit (more than $15 million) (7) and the 
cost of an ampoule of  DMPA is calculated $396 for every 
one annually (10). WHO focuses that for using effective 
and modern methods there is a need for health care givers 
who people trust and accept them, so midwives and health 
care givers could find out their requires and counsel with 
women desiring DMPA injection and they follow up 
then. Prevention of pregnancy is one of a midwife task in 
terms of reproductive and sexual health and she uses this 
opportunity for promotion of their health (24). Due to 
DMPA low failure rate, its higher cost and higher rate of 
its discontinuation, researchers were designed to study the 
continuation rate and different reasons of discontinuation 
of DMPA in culturally different cities like Tabriz & Ardebil. 
The results of this study could help health authorities to 
elevate rate of continuation and reduce its side-effects in 
order to prevent unwanted pregnancies and help their well-
being and reinforce economic of country. Also it is better 
to know the reasons of no using of effective contraception 
to prevent unintended and unwanted pregnancies. This 




This cross sectional-descriptive study was designed 
retrospectively on 396 and 484 DMPA user women aged 
15-49 years referring to health care centers in Ardabil & 
Tabriz respectively by classification sampling who were 
injected their first DMPA between 2009-2012. Due to 
being a cross sectional study 800 women were selected 
(400 for Ardabil and 400 for Tabriz) by this formula:
2 2
2 2
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And numbers were like as P & Q numbers from KAP 
study on DMPA by Moham Alizade et al. (14). This study 
was designed due to little information about continuation 
and discontinuations rate of DMPA and its reasons in 
our rejoin by reviewing books and articles in this field a 
questionnaire was arranged at two parts: demographic and 
main reasons for continuation and discontinuation and 
its side-effects. Then data were collected via completing 
questionnaires by researchers and interviewing subjects 
after signing the consent form. Data were analyzed by 
SPSS 12 software using analysis variance (ANOVA) and 
correlation. The method of content validity is used for 
validity of questionnaire in which 8 academic members 
of nursing faculty and 2 academic members of socio-
medical group of Ardabil & Tabriz gave their viewpoints 
and then they were corrected respectively. Reliability of 
questionnaire was based on retest method in which 30 
subjects completed it and after 10 days questionnaire was 
filled by them. Then Pierson relationship coefficient was 
measured about 0.85.
Questionnaire was arranged at two parts: demographic and 
main reasons for continuation and discontinuation and 
its side-effects. Then data were collected via completing 
questionnaires by researchers and interviewing subjects 
after signing the consent form. Data were analyzed by 
SPSS 12 software using analysis variance (ANOVA) and 
correlation. The results in Tabriz showed that the mean 
age of the study population was 33.6±6.2 years. The 
majority of the users were housewives (89.9%). The mean 
marriage age of the study population was 13.8±6.7 years 
old. Most of them (171 persons) had 10-19 years marriage 
long. Most of them (34.9) had primary educational level. 
50.4% of them had less than 3 pregnancies and 47.3% with 
2 children. The method of birth control before DMPA was 
OCPs (46.9%) and 24.5% of them did not continue it for its 
side-effects. 6,9.12 and 24 month cumulative continuation 
rate of DMPA were recorded as 58.8%, 35.1%, 21.6% 
and 9.1% respectively (Table 1). The most reason for 
selecting DMPA was its low failure rate of pregnancy.  The 
most side-effects reveled by women after injection was 
cease of bleeding (59.8%), weight gain (18.3%), spotting 
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(12.1%) and Headaches (5.8%). The main reason for 
discontinuations of DMPA was cease of bleeding (14.9%). 
As result of this study showed an association between 
continuation and husband educational level and the form 
of previous delivery (p<0.05). The mean of continuation 
rate mostly were 9 months among illiterate women and 
at least 5.31 months for highly educated women. There 
was no association between moderate continuation and 
variables such as age, educational level, occupations, 
husband occupations, family wage and number of 
pregnancies and children. The mean of continuation rate 
mostly was among women aged 30-39 years (Table 2). 
Results
The results in Ardebil showed that the mean age of the 
study population between 14-59 years old was 32±7.8 
years, the majority of the users were housewives (95%) 
and only 20 of them (5%) were employed. 33.8% of 
them had primary educational level. 70.5% of them 
had less than 3 pregnancies and 39.7% with 2 children. 
The method of birth control before DMPA was OCPs 
(75.3%) and 24.5% of them did not continue it for its 
side-effects. The most reason for selecting DMPA was 
health care giver personnel recommendations. The most 
side-effects reveled by women after injection was cease 
of bleeding (69.7%), backaches(13.4%), weight gain 
(10.9%), and  Headaches (10.4%). 6, 9, 12 and 24 month 
cumulative continuation rate of DMPA were recorded as 
44.5%, 26.5%, 18.2% and 2.3% respectively. (Table 3)  The 
main reason for discontinuations of DMPA was cease of 
bleeding (54.5%) (Table 4).  As result of this study showed 
an association between continuation and educational level 
and the number of pregnancies and children (p<0.05). 
The mean of continuation rate mostly were 7.62 months 
among illiterate women and at least 4.31 months for highly 
educated women. There was no association between 
moderate continuation rate and variables such as age and 
occupations. The mean of continuation rate mostly was 
among women aged 30-39 years (7.22 months).  
Totally, the mean of continuation rate of DMPA is 2.60 
and 6.52 months at Ardebil and Tabriz respectively. By 
using t-test the mean of continuation rate differs between 
two cities and its rate is higher at Tabriz.
Table 1.  Frequency of subjects due to DMPA continuation rate at Tabriz n=484.
Frequency percent Percent Frequency Number Continuation rate (months)
100 40.3 473 195 3
58.8 23.1 278 112 6
35.1 13.2 661 64 9
21.6 6.6 210 32 12
14.8 5.6 70 27 13-23
9.1 3.3 43 16 24
19.9 1.9 94 9 24 more than 
Table 2. Distributive frequency of subjects due to reasons of discontinuation of DMPA at Tabriz (n=484).
Frequency Reasons of discontinuation of 
DMPA
Frequency
Reasons of discontinuation of DMPA
Percent Number Percent Number
- - Low sexual desire - - Malignancy
1.2 6 Backache 0.2 1 Husband proponents
1.7 8 Leg pain 2.1 10 Long lasting bleeding time
0.2 1 Vision problem 2.1 10 Decrease of bleeding
0.6 3 Face pigmentation 3.1 15 Increase of  bleeding
1.2 6 Fatigue 2.7 13 Low bleeding
0.2 1 Acne 14/9 72 Amenorrhea
- - Less effective to prevent pregnancy 4.8 23 Spotting
- - No need to use for being away from husband 0.8 4 Breast tenderness
0.6 3 Desire to be pregnant 3.3 16 Weight gain
- - Lack of sufficient information 12.1 10 Headache & dizziness
- - Low quality of care - - Nausea
- - Sickness 1.7 8 Getting anger
3.1 15 Other reasons* 0.2 1 Hair loss
0.4 2 Hirsutism
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Table 4. Descriptive frequency of subjects due to reasons of 
discontinuation of DMPA at Ardabil (n=396).
Frequency
Reasons of Discontinuation of DMPA% N
54.5 216 Amenorrhea
8.8 35 Weight gain
8.1 32 Backache
7.1 28 Leg pain
7.1 28 Headache  
5.6 22 Increase of  bleeding
5.6 22 Spotting
3.5 14 Desire to pregnancy
Table 3. Frequency of subjects due to DMPA continuation rate at 
Ardabil.





















More than 24 
Discussion
Results of this study showed the mean of continuation 
rate of 6 months and 1 year DMPA was 44.5% and 18.2% 
at Ardebil and 58.8% and 21.6% in Tabriz. At a study 
by Aktun  et al. the mean of continuation rate of 1 year 
reported 64% (6). While at a study by Beksinska et al. at 
south Africa the mean of continuation rate of 6 months 
and 1 year DMPA reported 42% and 21% (15) which is 
coincided with the results of this study. At a KAP study on 
DMPA by Mohammad Alizadeh et al. at Tabriz the mean 
of continuation rate of 12 months DMPA was reported 
33% (14). The different reasons were due to cultural 
and social-economical issues (19). The main reason for 
discontinuations of DMPA at Ardebil and Tabriz was 
cease of menstrual bleeding (54.5%, 14.9%) respectively. 
At a study by Hajikazemi et al., the most common reasons 
were bleeding irregularity (53.6%), Amenorrhea (50.6%), 
Headaches (33%) and low desire & libido (20.3%) which 
is coincided with results of this study (17). At study 
by Mohammad Alizadeh et al. the main reasons for 
discontinuations of DMPA at Tabriz was reported cease 
of menstrual bleeding (25.6%), heavy bleeding (13.7%) 
(14). At a study by Aktun et al. the important reason for 
discontinuations of DMPA was reported irregular bleeding 
(51%) (10). At a study by Soltani et al. the important reason 
for discontinuations of DMPA was reported Amenorrhea 
(43%) and then irregular bleeding (35%) (21). As result 
of this study showed the most common side-effects  were 
cease of menstrual bleeding (69.7%, 19.8%), backaches 
(13.4%), weight gain (10.9%, 8.7%), and  Headaches 
(10.4%). As result of study by Afkari et al. the most 
common side-effect was menstrual disorders (86.1%) 
and then getting anger (25.2%), weight gain (22.2%). 
The most common menstrual disorders were cease of 
menstrual bleeding (53.2%) and spotting (26.7%) (18). 
Moreover, at a study by Soltani et al. the most common 
menstrual disorders were low volume of menstrual 
bleeding (63.4%)  Amenorrhea (55.7%) and then irregular 
bleeding (35%), high intervals between menstrual periods 
(39.6%) (21). At a study by Aktun et al.  (2005) the most 
common side-effects were menstrual disorders (80%), 
weight gain (10%), breast tenderness (6%) and Headaches 
(5%) (10) that all studies results due to  menstrual 
disorders are coincided with results of this study.  As 
result of this study showed an association between mean 
continuation and variables such as educational level and 
the number of pregnancies and children (p<0.05). There 
was no association between mean continuation rate and 
variables of educational level of mother and his spouse 
and the number of children by Rakhshani et al. study (13). 
However, there was association between these variables by 
Mohammad Alizadeh et al. study (14). The different result 
could be due to differences at sample size. As this study 
has done retrospectively so it is recommended to conduct 
a prospectively study in this field to find out precise side-
effects of DMPA and then follow up.
Conclusion 
According to the results of this study focusing on low level 
of continuation rate of DMPA at both cities and it is most 
common side-effect (Amenorrhea) care givers could help 
in term of sufficient counseling and educating women 
desiring DMPA injection. This factor could result in more 
satisfaction use and improve continuation rate of DMPA.
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